Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 1.56
NYSE:HUM's Cash-to-Debt is ranked lower than
61% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.15 vs. NYSE:HUM: 1.56 )
Ranked among companies with meaningful Cash-to-Debt only.
NYSE:HUM' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01  Med: 0.78 Max: 27.27
Current: 1.56
0.01
27.27
Equity-to-Asset 0.30
NYSE:HUM's Equity-to-Asset is ranked lower than
56% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.38 vs. NYSE:HUM: 0.30 )
Ranked among companies with meaningful Equity-to-Asset only.
NYSE:HUM' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.25  Med: 0.38 Max: 0.55
Current: 0.3
0.25
0.55
Debt-to-Equity 0.51
NYSE:HUM's Debt-to-Equity is ranked higher than
58% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.59 vs. NYSE:HUM: 0.51 )
Ranked among companies with meaningful Debt-to-Equity only.
NYSE:HUM' s Debt-to-Equity Range Over the Past 10 Years
Min: 0  Med: 0.41 Max: 0.9
Current: 0.51
0
0.9
Debt-to-EBITDA 1.87
NYSE:HUM's Debt-to-EBITDA is ranked higher than
72% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.82 vs. NYSE:HUM: 1.87 )
Ranked among companies with meaningful Debt-to-EBITDA only.
NYSE:HUM' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.74  Med: 1.23 Max: 1.87
Current: 1.87
0.74
1.87
Beneish M-Score: -3.17
WACC vs ROIC
7.27%
-109.57%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Net Margin % 2.49
NYSE:HUM's Net Margin % is ranked higher than
67% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.87 vs. NYSE:HUM: 2.49 )
Ranked among companies with meaningful Net Margin % only.
NYSE:HUM' s Net Margin % Range Over the Past 10 Years
Min: 1.13  Med: 3.05 Max: 4.55
Current: 2.49
1.13
4.55
ROE % 13.07
NYSE:HUM's ROE % is ranked higher than
73% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 15.89 vs. NYSE:HUM: 13.07 )
Ranked among companies with meaningful ROE % only.
NYSE:HUM' s ROE % Range Over the Past 10 Years
Min: 5.84  Med: 14.85 Max: 23.85
Current: 13.07
5.84
23.85
ROA % 4.27
NYSE:HUM's ROA % is ranked higher than
68% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.25 vs. NYSE:HUM: 4.27 )
Ranked among companies with meaningful ROA % only.
NYSE:HUM' s ROA % Range Over the Past 10 Years
Min: 2.45  Med: 6.27 Max: 9.31
Current: 4.27
2.45
9.31
3-Year Revenue Growth Rate 5.90
NYSE:HUM's 3-Year Revenue Growth Rate is ranked lower than
57% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.60 vs. NYSE:HUM: 5.90 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NYSE:HUM' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -26.1  Med: 9.9 Max: 28.7
Current: 5.9
-26.1
28.7
3-Year EBITDA Growth Rate 21.80
NYSE:HUM's 3-Year EBITDA Growth Rate is ranked higher than
65% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.70 vs. NYSE:HUM: 21.80 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
NYSE:HUM' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: 12.1 Max: 66.2
Current: 21.8
0
66.2
3-Year EPS without NRI Growth Rate 31.70
NYSE:HUM's 3-Year EPS without NRI Growth Rate is ranked higher than
69% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 17.70 vs. NYSE:HUM: 31.70 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
NYSE:HUM' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: 4.2 Max: 41.9
Current: 31.7
0
41.9
GuruFocus has detected 4 Warning Signs with Humana Inc NYSE:HUM.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NYSE:HUM's 30-Y Financials

Financials (Next Earnings Date: 2018-11-08)


Revenue & Net Income
Equity & Asset
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2017

HUM Guru Trades in Q3 2017

Caxton Associates 1,900 sh (New)
Paul Tudor Jones 17,016 sh (+225.42%)
Mario Gabelli 8,875 sh (+71.50%)
Jim Simons 3,660,100 sh (+34.02%)
Lee Ainslie 21,200 sh (+27.63%)
Joel Greenblatt 21,327 sh (+1.97%)
Vanguard Health Care Fund 215,600 sh (unchged)
Eaton Vance Worldwide Health Sciences Fund 83,440 sh (unchged)
Daniel Loeb Sold Out
Andreas Halvorsen Sold Out
Larry Robbins Sold Out
Steven Cohen Sold Out
Jeremy Grantham 531,675 sh (-6.58%)
Pioneer Investments 363,277 sh (-16.91%)
» More
Q4 2017

HUM Guru Trades in Q4 2017

Leon Cooperman 171,353 sh (New)
Steven Cohen 162,669 sh (New)
Lee Ainslie 36,410 sh (+71.75%)
Mario Gabelli 10,645 sh (+19.94%)
Pioneer Investments 402,658 sh (+10.84%)
Joel Greenblatt 22,153 sh (+3.87%)
Vanguard Health Care Fund 215,600 sh (unchged)
Eaton Vance Worldwide Health Sciences Fund 83,440 sh (unchged)
Caxton Associates Sold Out
Paul Tudor Jones 16,844 sh (-1.01%)
Jeremy Grantham 493,251 sh (-7.23%)
Jim Simons 3,241,700 sh (-11.43%)
» More
Q1 2018

HUM Guru Trades in Q1 2018

Larry Robbins 146,560 sh (New)
Lee Ainslie 45,140 sh (+23.98%)
Pioneer Investments 425,147 sh (+5.59%)
Jim Simons 3,249,100 sh (+0.23%)
Vanguard Health Care Fund 215,600 sh (unchged)
Eaton Vance Worldwide Health Sciences Fund 83,440 sh (unchged)
Paul Tudor Jones Sold Out
Steven Cohen Sold Out
Joel Greenblatt 18,104 sh (-18.28%)
Leon Cooperman 133,453 sh (-22.12%)
Mario Gabelli 7,728 sh (-27.40%)
Jeremy Grantham 171,615 sh (-65.21%)
» More
Q2 2018

HUM Guru Trades in Q2 2018

Steven Cohen 156,600 sh (New)
Pioneer Investments 703,980 sh (+65.59%)
Leon Cooperman 185,253 sh (+38.82%)
Vanguard Health Care Fund 215,600 sh (unchged)
Jeremy Grantham Sold Out
Larry Robbins Sold Out
Mario Gabelli 7,403 sh (-4.21%)
Jim Simons 2,783,500 sh (-14.33%)
Lee Ainslie 36,040 sh (-20.16%)
Joel Greenblatt 3,799 sh (-79.02%)
Eaton Vance Worldwide Health Sciences Fund 56,132 sh (-32.73%)
» More
» Details

Insider Trades

Latest Guru Trades with HUM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Leon Cooperman 2018-06-30 Add 38.82%0.54%$273.25 - $306.95 $ 328.3812%185,253
Mario Gabelli 2018-06-30 Reduce -4.21%$273.25 - $306.95 $ 328.3812%7,403
Joel Greenblatt 2018-06-30 Reduce -79.02%0.06%$273.25 - $306.95 $ 328.3812%3,799
Leon Cooperman 2018-03-31 Reduce -22.12%0.35%$251.28 - $291.23 $ 328.3821%133,453
Joel Greenblatt 2018-03-31 Reduce -18.28%0.01%$251.28 - $291.23 $ 328.3821%18,104
Mario Gabelli 2018-03-31 Reduce -27.40%0.01%$251.28 - $291.23 $ 328.3821%7,728
Leon Cooperman 2017-12-31 New Buy1.59%$233.28 - $258.97 $ 328.3833%171,353
Joel Greenblatt 2017-12-31 Add 3.87%$233.28 - $258.97 $ 328.3833%22,153
Mario Gabelli 2017-12-31 Add 19.94%$233.28 - $258.97 $ 328.3833%10,645
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Plans » Health Care Plans    NAICS: 621610    SIC: 6324
Compare:NYSE:CI, NAS:ESRX, NYSE:AET, NYSE:ANTM, NYSE:CNC, NYSE:CVS, NYSE:WCG, NYSE:MOH, BSP:ODPV3, BSP:QUAL3, NAS:MGLN, XPAR:GDS, NAS:HIIQ, OSTO:MCOV B, ROCO:6665, ATH:IATR, ASX:ONT, TSXV:NAC, MIL:HI, OTCPK:HFRN » details
Traded in other countries:HUM.Germany,
Headquarter Location:USA
Humana Inc is a health care company that offers insurance products and health and wellness services. Its segments include Retail, Employer Group and Healthcare Services.

Humana Inc is one of the largest and best-known providers of Medicare Advantage plans in the U.S. The firm specializes in providing government-sponsored plans, with close to three fourths of its membership tied to Medicare, Medicaid, or some other form of government healthcare program. Humana is also building an extensive provider network in key geographic areas in order to control the use and cost of healthcare services to its membership. These network and the firm's brand name will also make it a major player in the nascent public exchange market.

Top Ranked Articles about Humana Inc

US Markets in Red Monday Synnex plunges despite beating estimations
U.S. markets are in negative territory on Monday, with tech and consumer stocks leading the selloff. Read more...
WeissLaw LLP: Kindred Healthcare Inc. Merger May Not Be in the Best Interests of KND Shareholders
KINDRED INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kindred Healthcare, Inc. - KND
Jim Simons: Pioneer Quant Manager A brilliant mathematician turned his mind to investing, and emerged a big winner
There is a popular anecdote that Jim Simons (Trades, Portfolio) tells of his early life: As a teen, he got a summer job at a garden supply store. But he was a failure as a stock boy because he was so forgetful, and so was demoted to floor sweeper, which he enjoyed. He drew laughs from his bosses when he told them about his plans to get a university degree in mathematics. Simons says he also failed as a computer programmer, saying he kept forgetting notations; inevitably he was fired. Read more...
Investor Expectations to Drive Momentum within Humana, Delta Air Lines, Pepsico, Nuance Communications, Sysco, and WPCS International — Discovering Underlying Factors of Influence
US Stock Market Bearish Wednesday Humana reported better-than-expected earnings, raised its forecast
Wall Street was down in Wednesday premarket trading with the main indexes reversing all-time highs. Read more...

Ratios

vs
industry
vs
history
PE Ratio 33.75
HUM's PE Ratio is ranked higher than
62% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 19.79 vs. HUM: 33.75 )
Ranked among companies with meaningful PE Ratio only.
HUM' s PE Ratio Range Over the Past 10 Years
Min: 4.26  Med: 11.09 Max: 53.01
Current: 33.75
4.26
53.01
Forward PE Ratio 19.38
HUM's Forward PE Ratio is ranked lower than
85% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.27 vs. HUM: 19.38 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 33.75
HUM's PE Ratio without NRI is ranked higher than
62% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 19.79 vs. HUM: 33.75 )
Ranked among companies with meaningful PE Ratio without NRI only.
HUM' s PE Ratio without NRI Range Over the Past 10 Years
Min: 4.26  Med: 11.09 Max: 53.01
Current: 33.75
4.26
53.01
Price-to-Owner-Earnings 23.00
HUM's Price-to-Owner-Earnings is ranked higher than
69% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 16.47 vs. HUM: 23.00 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
HUM' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 2.73  Med: 10.14 Max: 87.11
Current: 23
2.73
87.11
PB Ratio 4.43
HUM's PB Ratio is ranked lower than
69% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.42 vs. HUM: 4.43 )
Ranked among companies with meaningful PB Ratio only.
HUM' s PB Ratio Range Over the Past 10 Years
Min: 0.71  Med: 1.8 Max: 4.57
Current: 4.43
0.71
4.57
PS Ratio 0.84
HUM's PS Ratio is ranked lower than
52% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.73 vs. HUM: 0.84 )
Ranked among companies with meaningful PS Ratio only.
HUM' s PS Ratio Range Over the Past 10 Years
Min: 0.11  Med: 0.39 Max: 0.87
Current: 0.84
0.11
0.87
Price-to-Free-Cash-Flow 15.70
HUM's Price-to-Free-Cash-Flow is ranked higher than
67% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.78 vs. HUM: 15.70 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
HUM' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 2.77  Med: 9.59 Max: 669.94
Current: 15.7
2.77
669.94
Price-to-Operating-Cash-Flow 13.18
HUM's Price-to-Operating-Cash-Flow is ranked higher than
65% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.15 vs. HUM: 13.18 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
HUM' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 2.5  Med: 7.79 Max: 53.04
Current: 13.18
2.5
53.04
EV-to-EBIT 14.58
HUM's EV-to-EBIT is ranked higher than
95% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.89 vs. HUM: 14.58 )
Ranked among companies with meaningful EV-to-EBIT only.
HUM' s EV-to-EBIT Range Over the Past 10 Years
Min: -0.7  Med: 3.6 Max: 15.3
Current: 14.58
-0.7
15.3
EV-to-EBITDA 11.86
HUM's EV-to-EBITDA is ranked higher than
95% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.81 vs. HUM: 11.86 )
Ranked among companies with meaningful EV-to-EBITDA only.
HUM' s EV-to-EBITDA Range Over the Past 10 Years
Min: -0.6  Med: 3.1 Max: 12.5
Current: 11.86
-0.6
12.5
EV-to-Revenue 0.60
HUM's EV-to-Revenue is ranked higher than
70% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.01 vs. HUM: 0.60 )
Ranked among companies with meaningful EV-to-Revenue only.
HUM' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.1  Med: 0.3 Max: 0.6
Current: 0.6
0.1
0.6
PEG Ratio 2.79
HUM's PEG Ratio is ranked higher than
54% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.35 vs. HUM: 2.79 )
Ranked among companies with meaningful PEG Ratio only.
HUM' s PEG Ratio Range Over the Past 10 Years
Min: 0.15  Med: 0.64 Max: 11.02
Current: 2.79
0.15
11.02
Shiller PE Ratio 38.00
HUM's Shiller PE Ratio is ranked lower than
62% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 27.53 vs. HUM: 38.00 )
Ranked among companies with meaningful Shiller PE Ratio only.
HUM' s Shiller PE Ratio Range Over the Past 10 Years
Min: 10.68  Med: 21.53 Max: 60.25
Current: 38
10.68
60.25

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.58
HUM's Dividend Yield % is ranked lower than
87% of the 31 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.02 vs. HUM: 0.58 )
Ranked among companies with meaningful Dividend Yield % only.
HUM' s Dividend Yield % Range Over the Past 10 Years
Min: 0.3  Med: 0.7 Max: 1.61
Current: 0.58
0.3
1.61
Dividend Payout Ratio 0.18
HUM's Dividend Payout Ratio is ranked higher than
93% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.27 vs. HUM: 0.18 )
Ranked among companies with meaningful Dividend Payout Ratio only.
HUM' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.09  Med: 0.14 Max: 0.21
Current: 0.18
0.09
0.21
3-Year Dividend Growth Rate 19.40
HUM's 3-Year Dividend Growth Rate is ranked higher than
50% of the 8 Companies
in the Global Health Care Plans industry.

( Industry Median: 19.40 vs. HUM: 19.40 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
HUM' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 19.4
Current: 19.4
0
19.4
Forward Dividend Yield % 0.61
HUM's Forward Dividend Yield % is ranked lower than
93% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.33 vs. HUM: 0.61 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 0.81
HUM's 5-Year Yield-on-Cost % is ranked lower than
92% of the 38 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.89 vs. HUM: 0.81 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
HUM' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.43  Med: 1 Max: 2.29
Current: 0.81
0.43
2.29
3-Year Average Share Buyback Ratio 2.70
HUM's 3-Year Average Share Buyback Ratio is ranked higher than
80% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: -0.50 vs. HUM: 2.70 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
HUM' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -2  Med: -0.3 Max: 3
Current: 2.7
-2
3

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 7.50
HUM's Price-to-Tangible-Book is ranked higher than
79% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.76 vs. HUM: 7.50 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
HUM' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.32  Med: 3.43 Max: 12.29
Current: 7.5
1.32
12.29
Price-to-Intrinsic-Value-Projected-FCF 1.77
HUM's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
80% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.08 vs. HUM: 1.77 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
HUM' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.29  Med: 0.86 Max: 1.89
Current: 1.77
0.29
1.89
Price-to-Intrinsic-Value-DCF (Earnings Based) 2.76
HUM's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
78% of the 9 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.02 vs. HUM: 2.76 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
HUM' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 0.27  Med: 0.74 Max: 4.44
Current: 2.76
0.27
4.44
Price-to-Median-PS-Value 2.16
HUM's Price-to-Median-PS-Value is ranked lower than
87% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.19 vs. HUM: 2.16 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
HUM' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.22  Med: 1.06 Max: 2.84
Current: 2.16
0.22
2.84
Price-to-Peter-Lynch-Fair-Value 3.45
HUM's Price-to-Peter-Lynch-Fair-Value is ranked lower than
64% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.09 vs. HUM: 3.45 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
HUM' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.23  Med: 0.74 Max: 18.45
Current: 3.45
0.23
18.45
Price-to-Graham-Number 3.35
HUM's Price-to-Graham-Number is ranked higher than
85% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.60 vs. HUM: 3.35 )
Ranked among companies with meaningful Price-to-Graham-Number only.
HUM' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.65  Med: 1.77 Max: 6.81
Current: 3.35
0.65
6.81
Earnings Yield (Greenblatt) % 6.86
HUM's Earnings Yield (Greenblatt) % is ranked higher than
96% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.22 vs. HUM: 6.86 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
HUM' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -3390  Med: 27.9 Max: 4111
Current: 6.86
-3390
4111
Forward Rate of Return (Yacktman) % 13.93
HUM's Forward Rate of Return (Yacktman) % is ranked lower than
63% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 16.01 vs. HUM: 13.93 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
HUM' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 6.9  Med: 25.5 Max: 42.6
Current: 13.93
6.9
42.6

More Statistics

Revenue (TTM) (Mil) $55,009.00
EPS (TTM) $ 9.73
Beta0.76
Volatility18.41%
52-Week Range $231.90 - 341.30
Shares Outstanding (Mil)137.76

Analyst Estimate

Dec18 Dec19 Dec20
Revenue (Mil $) 56,118 60,099 66,488
EBIT (Mil $) 2,636 3,141 4,065
EBITDA (Mil $) 3,072 3,325 4,523
EPS ($) 12.01 16.41 19.02
EPS without NRI ($) 12.01 16.41 19.02
EPS Growth Rate
(Future 3Y To 5Y Estimate)
13.60%
Dividends per Share ($) 1.58 1.60 1.60

Piotroski F-Score Details

Piotroski F-Score: ----
Positive ROAN
Positive CFROAN
Higher ROA yoyN
CFROA > ROAN
Lower Leverage yoyN
Higher Current Ratio yoyN
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}